Mission Bio and SequMed Sign Collaboration Agreement Announcing Partnership to Provide Tapestri Services and Co-Develop Clinical Applications in China

GUANGZHOU, China and SOUTH SAN FRANCISCO, Calif.: GUANGZHOU, China and SOUTH SAN FRANCISCO, Calif., Dec. 30, 2021 /PRNewswire/ -- Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, has signed an agreement with SequMed, a pioneer in single-cell omics technology innovation and applications in China. The agreement will...

Click to view original post